Dear NMusers,

 

This is the second announcement for the:

 

Advanced course on Pharmacometrics

16 - 18 Nov. 2015

Château de Longcol, Longcol, La Fouillade (France)

 

This is a 4-day course designed to develop and implement a
drug-disease-trial model strategy for optimizing the drug development
process using convolution-based methodologies and optimal design strategies.

 

Course outline

*       Determine the modelling strategy for characterizing the in-vivo
absorption processes for extended release formulations using
convolution-based approach
*       Evaluate In-Vitro/In-Vivo correlation methods, including
convolution-deconvolution approach using the NONMEM software
*       Evaluate the relationship between extended release drug exposure and
clinical response in presence of placebo effect and acute tolerance
*       Determine the relationship between drug delivery and clinical
response
*       Determine the In-Vitro drug release appropriate for optimizing the
clinical response
*        <http://www.pharmacometrica.com/> Determine the optimal study
design methodology for study in a pediatric population for extended release
formulations using the PopED software

 

Course objectives

*       To develop population PK models for describing multiphase absorption
profiles 
*       To evaluate alternative placebo response models 
*       To develop indirect-response model to jointly evaluate the placebo
and drug relate response
*       To evaluate the relative impact of the immediate and the delayed
drug release on the therapeutic response
*       To use convolution-deconvolution methods for linking in-vitro to
in-vivo outcomes 
*       To determine the optimal drug formulation profiles for optimizing
the performances of novel drug formulations 
*       To evaluate optimal study design methodologies
*       To present and use in the hands-on session an R based package for
implementing: 

a.    the convolution/deconvolution analysis, 

b.    a clinical trial simulator for describing the clinical response in
presence of placebo and active drug response,

c.    the estimation of the optimal in-vitro dissolution profiles

 

 

Additional details are available at:
<http://pharmacometricaworkshop.webs.com/>
http://pharmacometricaworkshop.webs.com/

 

 

 

Roberto Gomeni, PhD, HDR, Adjunct Professor at UNC

Pharmacometrica

Longcol, 12270 La Fouillade (France)

E-mail:  <mailto:[email protected]>
[email protected]

 <http://www.pharmacometrica.com/> www.pharmacometrica.com

Next workshops on pharmacometrics:
<http://pharmacometricaworkshop.webs.com/>
http://pharmacometricaworkshop.webs.com/

 

 

 

Attachment: image001.emz
Description: Binary data

Reply via email to